Drug Trial Radar · NCT05680818
Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1
Last checked: Nov 20, 2026Latest source record: Jul 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
67
Actual
Start
Jan 6, 2023
Primary completion
Aug 22, 2025
Study completion Aug 2029
Sponsor
- Lead sponsor
- Calcilytix Therapeutics, Inc., a BridgeBio companyIndustry
- Sponsor type
- Industry
- First posted
- Jan 11, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of the study is to understand the effectiveness, safety, and tolerability of encaleret when compared to standard of care (SoC) treatment in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1).
Conditions
- Autosomal Dominant Hypocalcemia (ADH)
Interventions
EncaleretDrug
Administered as film-coated tablet for oral use
Standard of CareDietary supplement
Calcium supplements and/or active Vitamin D (calcitriol, alfacalcidol, falecalcitriol, etc.)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Responders who Achieve Both Albumin-Corrected Blood Calcium (cCa) and 24-hour Urinary Calcium (UCa) Within the Target RangeTime frame: Up to Week 24
Locations
25 sites in 10 countries. Site status is shown where the registry gives one.
UCSF Benioff Children's Hospital, Oakland
Oakland, California
Children's Hospital Colorado
Aurora, Colorado
Indiana University Health University Hospital
Indianapolis, Indiana
NIH
Bethesda, Maryland
Massachusetts General Hospital
Boston, Massachusetts
Mayo Clinic - Rochester
Rochester, Minnesota
Columbia University Irving Medical Center
New York, New York
Physicians East
Greenville, North Carolina
Ohio State University Medical Center
Columbus, Ohio
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Houston Methodist Hospital
Houston, Texas
Royal North Shore Hospital
Saint Leonards, New South Wales, Australia
Royal Brisbane and Women's Hospital
Herston, Queensland, Australia
Bone Research & Education Centre
Oakville, Ontario, Canada
Vseobecna fakultni nemocnice v Praze
New Town, Czechia
Aarhus University Hospital
Aarhus, Denmark
Hôpital Edouard Herriot - HCL
Lyon, France
CHU Bicetre
Le Kremlin-Bicêtre, Le Kremlin-Bicêtre, France
IRCCS Ospedale San Raffaele
Milan, Italy
University Hospital of Pisa
Pisa, Italy
Fondazione Policlinico Universitario Campus Bio-Medico
Roma, Italy
The University of Tokyo Hospital
Tokyo, Japan
Eramus MC
Rotterdam, Netherlands
Freeman Hospital
Newcastle upon Tyne, United Kingdom
Norfolk and Norwich University Hospital
Norwich, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.